Showing results (121-130 of 162) with videos related to
Sort By:
Pageof 17
Lung Cancer (Amsterdam, Netherlands)|May 15, 2013
Anaplastic lymphoma kinase (ALK) gene rearrangement in non-small cell lung cancer (NSCLC): results of a multi-centre ALK-testingMaximilian V Laffert, Arne Warth, Roland Penzel, et al.British Journal of Cancer|February 22, 2023
Genomic ALK alterations in primary and relapsed neuroblastomaCarolina Rosswog, Jana Fassunke, Angela Ernst, et al.Genes, Chromosomes & Cancer|October 26, 2019
Testing NTRK testing: Wet-lab and in silico comparison of RNA-based targeted sequencing assaysNicole Pfarr, Martina Kirchner, Ulrich Lehmann, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 10, 2023
MET Fusions in NSCLC: Clinicopathologic Features and Response to MET InhibitionRichard Riedel, Jana Fassunke, Andreas H Scheel, et al.Lung Cancer (Amsterdam, Netherlands)|August 28, 2022
Alectinib for the treatment of pretreated RET-rearranged advanced NSCLC: Results of the ETOP ALERT-lung trialEnriqueta Felip, Egbert F Smit, Miguel A Molina-Vila, et al.Lung Cancer (Amsterdam, Netherlands)|May 4, 2020
Co-occurrence of targetable mutations in Non-small cell lung cancer (NSCLC) patients harboring MAP2K1 mutationsMatthias Scheffler, Alessandra Holzem, Anna Kron, et al.Der Pathologe|December 1, 2020
[Diagnosis and therapy of tumors with NTRK gene fusion]Albrecht Stenzinger, Cornelis M van Tilburg, Ghazaleh Tabatabai, et al.Oncotarget|April 15, 2015
ROS1 rearrangements in lung adenocarcinoma: prognostic impact, therapeutic options and genetic variabilityMatthias Scheffler, Anne Schultheis, Cristina Teixido, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2014
MET amplification status in therapy-naïve adeno- and squamous cell carcinomas of the lungHans-Ulrich Schildhaus, Anne M Schultheis, Josef Rüschoff, et al.The Journal of Molecular Diagnostics : JMD|March 25, 2020
Evaluation of a Hybrid Capture-Based Pan-Cancer Panel for Analysis of Treatment Stratifying Oncogenic Aberrations and ProcessesLeonie I Kroeze, Richarda M de Voer, Eveline J Kamping, et al.Pageof 17